Z Kassam1,2, C Cribb Fabersunne3,4, M B Smith1,2, E J Alm1, G G Kaplan5, G C Nguyen6, A N Ananthakrishnan3,7. 1. Massachusetts Institute of Technology, Cambridge, MA, USA. 2. OpenBiome, Medford, MA, USA. 3. Harvard Medical School, Boston, MA, USA. 4. Harvard School of Public Health, Boston, MA, USA. 5. University of Calgary, Calgary, AB, Canada. 6. Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, ON, Canada. 7. Massachusetts General Hospital, Boston, MA, USA.
Abstract
BACKGROUND: Clostridium difficile infection (CDI) is a public health threat and associated with significant mortality. However, there is a paucity of objectively derived CDI severity scoring systems to predict mortality. AIM: To develop a novel CDI risk score to predict mortality entitled: Clostridium difficile associated risk of death score (CARDS). METHODS: We obtained data from the United States 2011 Nationwide Inpatient Sample (NIS) database. All CDI-associated hospitalisations were identified using discharge codes (ICD-9-CM, 008.45). Multivariate logistic regression was utilised to identify independent predictors of mortality. Clostridium difficile associated risk of death score was calculated by assigning a numeric weight to each parameter based on their odds ratio in the final logistic model. Predictive properties of model discrimination were assessed using the c-statistic and validated in an independent sample using the 2010 NIS database. RESULTS: We identified 77 776 hospitalisations, yielding an estimate of 374 747 cases with an associated diagnosis of CDI in the US, 8% of whom died in the hospital. The eight severity score predictors were identified on multivariate analysis: age, cardiopulmonary disease, malignancy, diabetes, inflammatory bowel disease, acute renal failure, liver disease and ICU admission, with weights ranging from -1 (for diabetes) to 5 (for ICU admission). The overall risk score in the cohort ranged from 0 to 18. Mortality increased significantly as CARDS increased. CDI-associated mortality was 1.2% with a CARDS of 0 compared to 100% with CARDS of 18. The model performed equally well in our validation cohort. CONCLUSION: Clostridium difficile associated risk of death score is a promising simple severity score to predict mortality among those hospitalised with C. difficile infection.
BACKGROUND:Clostridium difficileinfection (CDI) is a public health threat and associated with significant mortality. However, there is a paucity of objectively derived CDI severity scoring systems to predict mortality. AIM: To develop a novel CDI risk score to predict mortality entitled: Clostridium difficile associated risk of death score (CARDS). METHODS: We obtained data from the United States 2011 Nationwide Inpatient Sample (NIS) database. All CDI-associated hospitalisations were identified using discharge codes (ICD-9-CM, 008.45). Multivariate logistic regression was utilised to identify independent predictors of mortality. Clostridium difficile associated risk of death score was calculated by assigning a numeric weight to each parameter based on their odds ratio in the final logistic model. Predictive properties of model discrimination were assessed using the c-statistic and validated in an independent sample using the 2010 NIS database. RESULTS: We identified 77 776 hospitalisations, yielding an estimate of 374 747 cases with an associated diagnosis of CDI in the US, 8% of whom died in the hospital. The eight severity score predictors were identified on multivariate analysis: age, cardiopulmonary disease, malignancy, diabetes, inflammatory bowel disease, acute renal failure, liver disease and ICU admission, with weights ranging from -1 (for diabetes) to 5 (for ICU admission). The overall risk score in the cohort ranged from 0 to 18. Mortality increased significantly as CARDS increased. CDI-associated mortality was 1.2% with a CARDS of 0 compared to 100% with CARDS of 18. The model performed equally well in our validation cohort. CONCLUSION:Clostridium difficile associated risk of death score is a promising simple severity score to predict mortality among those hospitalised with C. difficileinfection.
Authors: Mary Y Hu; Kianoosh Katchar; Lorraine Kyne; Seema Maroo; Sanjeev Tummala; Valley Dreisbach; Hua Xu; Daniel A Leffler; Ciarán P Kelly Journal: Gastroenterology Date: 2008-12-13 Impact factor: 22.682
Authors: Christina M Surawicz; Lawrence J Brandt; David G Binion; Ashwin N Ananthakrishnan; Scott R Curry; Peter H Gilligan; Lynne V McFarland; Mark Mellow; Brian S Zuckerbraun Journal: Am J Gastroenterol Date: 2013-02-26 Impact factor: 10.864
Authors: María E Negrón; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Marie-Claude Proulx; Alexandra Frolkis; Paul L Beck; Levinus A Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan Journal: Can J Gastroenterol Hepatol Date: 2014 Jul-Aug
Authors: S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee Journal: Clin Microbiol Infect Date: 2011-06-10 Impact factor: 8.067
Authors: T Inns; R Gorton; A Berrington; A Sails; T Lamagni; J Collins; J Perry; K Hill; J Magee; K Gould Journal: J Hosp Infect Date: 2013-06-10 Impact factor: 3.926
Authors: Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin Journal: N Engl J Med Date: 2014-03-27 Impact factor: 91.245
Authors: Hisham Hussan; Emmanuel Ugbarugba; Michael T Bailey; Kyle Porter; Bradley Needleman; Sabrena Noria; Benjamin O'Donnell; Steven K Clinton Journal: Obes Surg Date: 2018-07 Impact factor: 4.129
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Michael D Kappelman; Christopher F Martin; Joshua R Korzenik; Seth D Crockett Journal: Inflamm Bowel Dis Date: 2017-06 Impact factor: 5.325
Authors: Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Seth D Crockett; Joshua R Korzenik; Michael D Kappelman Journal: J Pediatr Date: 2017-10-14 Impact factor: 4.406
Authors: J R Allegretti; S Kearney; N Li; E Bogart; K Bullock; G K Gerber; L Bry; C B Clish; E Alm; J R Korzenik Journal: Aliment Pharmacol Ther Date: 2016-04-18 Impact factor: 8.171
Authors: D Alexander Perry; Daniel Shirley; Dejan Micic; Pratish C Patel; Rosemary Putler; Anitha Menon; Vincent B Young; Krishna Rao Journal: Clin Infect Dis Date: 2022-06-10 Impact factor: 20.999
Authors: O H Negm; B MacKenzie; M R Hamed; O A J Ahmad; C C Shone; D P Humphreys; K Ravi Acharya; C E Loscher; I Marszalowska; M Lynch; M H Wilcox; T M Monaghan Journal: Clin Exp Immunol Date: 2017-03-16 Impact factor: 4.330